Skip to content

Emergent Biosolutions EBS Operating Lease Weighted Average Discount Rate Percent

Operating Lease Weighted Average Discount Rate Percent at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
BioLife Solutions logo
BioLife SolutionsBLFS
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%
EPS (diluted)$0.07-94.1%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Market cap$411.74M+22.0%
Enterprise value$834.84M-2.6%
P/E3.6×
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin20.8%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's operating lease weighted average discount rate percent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's operating lease weighted average discount rate percent?
Emergent Biosolutions (EBS) reported operating lease weighted average discount rate percent of $0.06 in Q1 2026.
How has Emergent Biosolutions's operating lease weighted average discount rate percent changed year-over-year?
Emergent Biosolutions's operating lease weighted average discount rate percent decreased by 3.0% year-over-year, from $0.07 to $0.06.
What is the long-term trend for Emergent Biosolutions's operating lease weighted average discount rate percent?
Over 5 years (2020 to 2025), Emergent Biosolutions's operating lease weighted average discount rate percent has grown at a 9.7% compound annual growth rate (CAGR), from $0.04 to $0.07.